<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940728-2-00084</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Centers for Disease Control and Prevention</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Technical Advisory Committee for Diabetes Translation and Community Control Programs; Reestablishment</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Notice of Reestablishment_Technical Advisory Committee for Diabetes Translation and Community Control Programs. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Pursuant to the Federal Advisory Committee Act, 5 U.S.C. Appendix 2, the Centers for Disease Control and Prevention announces the reestablishment of the following Federal advisory committee by the Secretary of Health and Human Services: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Designation: Technical Advisory Committee for Diabetes Translation and Community Control Programs. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Purpose: The Committee shall advise the Director, Centers for Disease Control and Prevention, regarding priorities and feasible goals for translation activities and community control programs designed to reduce risk factors, morbidity, and mortality associated with diabetes and its complications. The Committee shall advise regarding policies, strategies, goals and objectives, and priorities; identify research advances and technologies ready for translation into widespread community practice; recommend public health strategies to be implemented through community interventions; advise on operational research and outcome evaluation methodologies; identify research issues for further clinical investigation; and advise regarding the coordination of programs with Federal, voluntary, and private resources involved in the provision of services to people with diabetes. <!-- PJG 0012 frnewline --> Authority for this committee will expire June 15, 1996, unless the Secretary of Health and Human Services, with the concurrence of the Committee Management Secretariat, General Services Administration, formally determines that continuance is in the public interest. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: July 21, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> William H. Gimson, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;18363 Filed 7&hyph;27&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4163&hyph;18&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            